Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. - Wikidata - awgldk - TriplyDB

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

http://www.wikidata.org/entity/Q36998081

about

Emerging drugs for uveitis Cyclosporine for ocular inflammatory diseases.Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.Role of oxygen free radicals in retinal damage associated with experimental uveitis Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat.Systemic therapies for inflammatory eye disease: past, present and future Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.Bench to bedside: new approaches to the immunotherapy of uveitic disease.Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.Endogenous posterior uveitis.Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Effects of cyclosporine in spontaneous, posterior uveitis.Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens.Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis?Immunotolerance and prevention of ocular autoimmune disease.Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report.Immunotherapy for Behçet's disease.A comparative approach to topical cyclosporine therapy.Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A Low dose cyclosporin A therapy in chronic posterior uveitis.Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation.Trials of vaccination against experimental autoimmune uveoretinitis with a T-cell receptor peptide.Sandimmun(®) (ciclosporin, Cyclosporin A) Past experience and present uses in autoimmune diseases.Prevention of experimental autoimmune uveoretinitis by intrathymic S-antigen injection

P2860

Q24630848-C9B5E53A-5132-46F7-85FF-3EF396403A03 Q33520584-FA7BA37C-F52A-404A-BE2F-144BDF345F1C Q33760317-1A49C8CD-B599-46F2-B0A3-0B378D06CD94 Q34164506-AB3A26D2-6D99-412C-9D2F-E3A99644F81B Q34566842-79283DBB-30E4-47F5-B12C-EAF27685055F Q34687332-F8E4095C-D1A8-4AAF-AF42-E551AEE4C824 Q34692643-DE715F5C-2F15-49BC-BB57-CDE81BE529ED Q34993229-0CF82EC8-A1B5-4667-8A6D-12D7443CC6A0 Q35298191-EEC45134-D49F-41C6-822E-4C789E554D2E Q35582940-392DE67E-016D-417D-A80F-28AA1708D971 Q35858507-4D172EB5-2BBD-4053-A379-09680E22BE2A Q36232654-CA54C69E-460E-462A-82BC-AAB13E0DC6A3 Q37262587-E1A5D0B1-FD18-4B3E-8742-FC1B780E4B10 Q37361237-0DFC8F5B-2E27-4CD3-A5D1-3C255155E010 Q38031601-01DA64BF-3FF1-4BC3-98CA-5DA5AB4F6B95 Q38168361-534F994B-1C02-4C0C-9D9F-4AD8A1792BDC Q38477174-F22098FC-28A7-4C23-B1FF-77E4E03700D1 Q39693140-977642B2-A0B6-4919-AA41-0D9B794F5AD0 Q39706642-02547056-47A1-4C57-88DC-7CD67FCA16D0 Q40909960-170156AA-D814-481E-A352-25CCC717236A Q40927838-1CAD25F4-BC10-4D3A-A6C5-C9E78B2142A9 Q40976391-30B3CC3B-AE22-48B6-A044-2BF551A76331 Q41514354-C899EB72-DEA7-43B1-BA85-43CA0A61F23B Q41678598-4F945793-262C-4D19-87F4-E7BF0ADFEC68 Q41719098-61C00602-81D9-4285-B313-68107D4AE86F Q44276629-30CBC6AA-8CF0-4B59-AE6B-DE0D868A2BA6 Q44621307-7EDD8BB0-C54D-4276-8E35-463D64B1EC0A Q44744832-15FC1278-AB5A-43E1-9E3F-F9AD7088F2C6 Q54249875-7DF716A0-7A94-4401-8572-192413FAFCE9 Q57281016-6E2B0ECE-6A69-4331-9CA2-72688DB56C3A

P2860

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

http://www.wikidata.org/entity/Q36998081

description

1981 nî lūn-bûn

@nan

1981年の論文

@ja

1981年論文

@yue

1981年論文

@zh-hant

1981年論文

@zh-hk

1981年論文

@zh-mo

1981年論文

@zh-tw

1981年论文

@wuu

1981年论文

@zh

1981年论文

@zh-cn

name

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

@en

type

label

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

@en

prefLabel

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

@en

P1433

Q36998081-CE207363-C93E-4305-9FAF-D88CBAFCD1B2

P1476

Q36998081-C4C0B627-9066-46BF-A523-E13AA80800E1

P2093

Q36998081-906EF1E4-14E0-4CCD-A5FF-CF658069EE19

Q36998081-AB526193-5D9D-46D0-BE81-5F44A86B48AB

Q36998081-AD32527F-D369-459A-A622-59C7F8DF574B

Q36998081-B126D8CC-AC3E-4934-8622-D516CB1D8887

Q36998081-D7E3CB51-805A-4013-950E-CA5BFF1B092A

Q36998081-F8A3AE1D-0E0D-46CB-A647-9322926A970D

P2860

Q36998081-0F8B8745-48ED-4491-B00E-E4CB4198842B

Q36998081-28C5769C-7D35-4E0B-A44D-ACB82ED2A3CB

Q36998081-35682A7A-E187-4E98-85C9-7CC168A9A187

Q36998081-4E6076A4-988B-4445-9058-DF237DB927C2

Q36998081-4FA3DB7D-6F2F-40AE-BD15-FF3106A3EA2F

Q36998081-63F5670A-58D9-4C2C-94C7-53EEAF5D39CC

Q36998081-D0BD6CE8-94BB-4314-BA7A-8272C216518A

P304

Q36998081-EC31150E-DB3A-4CC0-94BC-0A0682584F4B

P31

Q36998081-DC8B8AE4-A1A2-4FCB-BD15-8F923A805C3C

P356

Q36998081-FE8C094F-162F-4E1B-AD2A-A350B30FF2BD

P407

Q36998081-97D194EF-EF3A-4A63-9A0A-AE7741C4EBF2

P433

Q36998081-1ABAA339-F34E-4FCF-BBB9-992572E447BD

P478

Q36998081-E2C8345C-85BC-4570-B12C-CEDCC916136A

P577

Q36998081-1AD29E3F-DD1A-4814-92D6-0F0B0EC0BEDE

P5875

Q36998081-BBE091CA-4501-4208-9370-0BDB610C69FE

P698

Q36998081-7A52C132-2FC6-477A-B503-69ACCA2C268A

P921

Q36998081-91EC94EA-306B-47BA-86A5-028B14F2B931

P932

Q36998081-DA1E779A-C231-4419-9A14-11A6A9351E1C

P356

P1433

Journal of Clinical Investigation

P1476

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

@en

P2093

Cevario SJ

http://www.w3.org/2001/XMLSchema#string

Gery I

http://www.w3.org/2001/XMLSchema#string

Nussenblatt RB

http://www.w3.org/2001/XMLSchema#string

Rodrigues MM

http://www.w3.org/2001/XMLSchema#string

Salinas-Carmona MC

http://www.w3.org/2001/XMLSchema#string

Wacker WB

http://www.w3.org/2001/XMLSchema#string

P2860

Biological effects of cyclosporin A: a new antilymphocytic agent

Use of cyclosporin A in allogeneic bone marrow transplantation in the rat.

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina.

Effect of cyclosporin A on the survival of corneal grafts in rabbits.

Experimental autoimmune uveitis: cellular immune responsiveness.

Cellular immune responsiveness of uveitis patients to retinal S-antigen.

P304

1228-1231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI110138

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

1981-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15993675

http://www.w3.org/2001/XMLSchema#string

P698

7204576

http://www.w3.org/2001/XMLSchema#string

P921

P932

370685

http://www.w3.org/2001/XMLSchema#string